All articles
MASH Landscape: Fibrosis Stage, Catalysts, China and Deals
Most MASH drugs are still early, and only nine industry molecules are in Phase III. See which programs target F2–F3 or F4, what reads out next, when approvals are expected, how much of the pipeline comes from China and who has been buying. Select any dot, cell, bar or row for the drugs and sources behind it.
